statistiche ricercatore

Continente	#
EU - Europa	1.201
NA - Nord America	1.064
AS - Asia	699
SA - Sud America	113
AF - Africa	24
OC - Oceania	4
Continente sconosciuto - Info sul continente non disponibili	2
Totale	3.107

Nazione	#
US - Stati Uniti d'America	1.021
PL - Polonia	514
IT - Italia	244
SG - Singapore	230
CN - Cina	142
DE - Germania	137
VN - Vietnam	107
BR - Brasile	85
SE - Svezia	65
HK - Hong Kong	58
FR - Francia	34
GB - Regno Unito	34
NL - Olanda	33
KR - Corea	32
BD - Bangladesh	29
IN - India	29
CA - Canada	28
RU - Federazione Russa	28
FI - Finlandia	17
TR - Turchia	17
IE - Irlanda	15
BG - Bulgaria	14
UA - Ucraina	12
BE - Belgio	11
JP - Giappone	10
AT - Austria	8
EC - Ecuador	8
MA - Marocco	8
MX - Messico	8
AR - Argentina	7
CH - Svizzera	7
IR - Iran	7
ZA - Sudafrica	7
ES - Italia	6
SA - Arabia Saudita	6
DK - Danimarca	4
ID - Indonesia	4
IQ - Iraq	4
MY - Malesia	4
PY - Paraguay	4
UZ - Uzbekistan	4
AU - Australia	3
CL - Cile	3
CZ - Repubblica Ceca	3
EG - Egitto	3
LT - Lituania	3
PK - Pakistan	3
RO - Romania	3
SN - Senegal	3
AE - Emirati Arabi Uniti	2
AL - Albania	2
DO - Repubblica Dominicana	2
KE - Kenya	2
PH - Filippine	2
VE - Venezuela	2
A2 - ???statistics.table.value.countryCode.A2???	1
AM - Armenia	1
AZ - Azerbaigian	1
BA - Bosnia-Erzegovina	1
BO - Bolivia	1
CO - Colombia	1
CR - Costa Rica	1
CY - Cipro	1
EE - Estonia	1
EU - Europa	1
GE - Georgia	1
GR - Grecia	1
GT - Guatemala	1
HN - Honduras	1
HR - Croazia	1
JO - Giordania	1
KG - Kirghizistan	1
LA - Repubblica Popolare Democratica del Laos	1
LB - Libano	1
LK - Sri Lanka	1
NI - Nicaragua	1
NZ - Nuova Zelanda	1
PA - Panama	1
PE - Perù	1
PT - Portogallo	1
SI - Slovenia	1
SK - Slovacchia (Repubblica Slovacca)	1
TN - Tunisia	1
UY - Uruguay	1
Totale	3.107

Nome	#
MicroRNAs as Regulators of Neo-Angiogenesis in Hepatocellular Carcinoma	412
Serum Stem Cell Growth Factor Beta for the Prediction of Therapy Response in Hepatocellular Carcinoma	391
Silencing efficacy prediction: a retrospective study on target mRNA features	390
Serum AP-endonuclease 1 (sAPE1) as novel biomarker for hepatocellular carcinoma	360
A new insight on the stem cell growth factor beta as astrong predictor of therapy response in hepatocellular carcinoma	328
Repeated double cross-validation applied to the PCA-LDA classification of SERS spectra: a case study with serum samples from hepatocellular carcinoma patients	229
MiR-3201 as a Prognostic Blood Biomarker for Curative Treatments in Hepatocellular Carcinoma	224
Weighted miRNA co-expression networks analysis identifies circulating miRNA predicting overall survival in hepatocellular carcinoma patients	195
Circulatory mirna as a biomarker for therapy response and disease-free survival in hepatocellular carcinoma	157
MicroRNAs Related to TACE Treatment Response: A Review of the Literature from a Radiological Point of View	154
Aurora kinase A and programmed death-ligand 1: expression dynamics in hepatocellular carcinoma development and the regulatory role of the kinase in immune checkpoint modulation	141
Bilirubin-Induced Transcriptomic Imprinting in Neonatal Hyperbilirubinemia	108
Clinical Significance of Apurinic/Apyrimidinic Endodeoxyribonuclease 1 and MicroRNA Axis in Hepatocellular Carcinoma	98
Totale	3.187

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	184	8	7	25	13	11	17	8	7	19	11	12	46
2022/2023	320	16	34	14	40	9	49	49	44	36	8	13	8
2023/2024	200	13	4	7	9	36	17	47	22	8	6	20	11
2024/2025	465	9	14	32	52	36	28	52	30	55	67	45	45
2025/2026	1.020	116	42	54	93	108	74	167	27	95	140	67	37
2026/2027	4	4	0	0	0	0	0	0	0	0	0	0	0
Totale													3.187

ArTS Archivio della ricerca di Trieste